Compare SFM & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SFM | TECH |
|---|---|---|
| Founded | 2002 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Chains | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.7B | 9.1B |
| IPO Year | 2013 | 1995 |
| Metric | SFM | TECH |
|---|---|---|
| Price | $73.55 | $71.79 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 11 |
| Target Price | ★ $98.89 | $71.82 |
| AVG Volume (30 Days) | 2.1M | ★ 7.6M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.62% |
| EPS Growth | ★ 41.60 | N/A |
| EPS | ★ 1.71 | 0.81 |
| Revenue | ★ $8,806,159,000.00 | $1,219,635,000.00 |
| Revenue This Year | $8.95 | $2.49 |
| Revenue Next Year | $7.36 | $6.40 |
| P/E Ratio | ★ $42.91 | $88.23 |
| Revenue Growth | ★ 14.08 | 5.23 |
| 52 Week Low | $64.75 | $43.20 |
| 52 Week High | $170.49 | $72.16 |
| Indicator | SFM | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 36.09 | 77.23 |
| Support Level | $66.35 | $70.49 |
| Resistance Level | $81.92 | $72.16 |
| Average True Range (ATR) | 4.41 | 0.40 |
| MACD | -1.24 | -0.25 |
| Stochastic Oscillator | 10.58 | 97.73 |
Sprouts Farmers Market Inc offers a specialty grocery experience featuring an open layout with fresh produce at the heart of the store. Sprouts inspire wellness naturally with a carefully curated assortment products paired with purpose-driven people. The company continues to bring products made with lifestyle-friendly ingredients such as organic, plant-based, and gluten-free. It approximately has 407 stores in nearly 23 states. The Company has one operating segment that is healthy grocery stores.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.